STOCK TITAN

DSS, Inc. - DSS STOCK NEWS

Welcome to our dedicated page for DSS news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on DSS stock.

DSS, Inc. (NYSE American: DSS) is a multinational conglomerate with a diversified business portfolio encompassing nine distinct divisions: Product Packaging, Biotechnology, Consumer Marketing, Commercial Lending, Securities and Investment Management, Alternative Trading, Secure Living, Digital Transformation, and Alternative Energy. Established over 25 years ago, DSS has a long-standing reputation in anti-counterfeit, authentication, and diversion protection technologies, offering custom solutions to safeguard against product diversion, counterfeit, theft, and other costly occurrences. Their innovative technologies, backed by numerous patents, are utilized by corporations, governments, and financial institutions worldwide.

Recently, DSS has focused on expanding its value through strategic acquisitions and periodic IPO spinoffs. Under the leadership of Frank Heuszel, DSS has built a diversified portfolio aimed at driving profitability and growth. Notable subsidiaries include DSS Wealth Management, which advises the AmericaFirst Quantitative Funds, and Premier Packaging, specializing in innovative fiber-based packaging solutions.

In recent developments, DSS appointed Jim Monaghan as Chief Operating Officer and Chief Compliance Officer, and Michael Cheah as Portfolio Manager & Head of Fixed Income at DSS Wealth Management. Both additions bring over 30 years of industry experience and are expected to enhance DSS's investment strategies and compliance standards. Moreover, DSS is preparing for the IPO of its subsidiary, Impact Biomedical, which promises to reinforce the company's growth trajectory.

DSS's recent accomplishments include a successful legal defense of their ‘040 patent in the Federal Circuit Court against Nichia Corp., further solidifying their strong IP portfolio. Additionally, Chairman Heng Fai Ambrose Chan's recent acquisition of 672,173 shares underscores his confidence in DSS's strategic direction and market potential.

For continuous updates and more detailed information, visit the official website at www.dssworld.com and follow their latest news and developments on Twitter at @docsecuritysys and @authentisuite.

Rhea-AI Summary

DSS (NYSE American: DSS) announced the appointment of Frank D. Heuszel and Sassuan (Sam) Lee to the board of Sharing Services Global Corp (OTCQB: SHRG), where DSS holds a 37% ownership stake. Heuszel expressed enthusiasm about leveraging his experience to enhance shareholder value and grow the company's independent representative network. The collaboration aims to expand Sharing Services' market reach and product offerings, enhancing its competitive position within the direct selling industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.44%
Tags
management
-
Rhea-AI Summary

Document Security Systems (DSS) has reaffirmed its plans for a two-part special share dividend of Impact BioMedical shares. Shareholders as of September 7, 2020, will receive two Bonus Shares for each DSS share held. The Bonus Shares will be distributed after Impact BioMedical's IPO, targeted for 2021. Although there are no guarantees regarding the IPO or share distribution due to market conditions, the company is committed to this path. Impact BioMedical, acquired by DSS in August 2020, holds antiviral technologies valued at $382 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
dividends
-
Rhea-AI Summary

Document Security Systems (DSS) announced a bioplastics research collaboration through its subsidiary Impact BioMedical. The partnership aims to develop five types of advanced microbial-resistant plastics to combat pathogens like SARS-CoV-2 and E. coli. Daryl Thompson, a noted researcher and twice Nobel nominee, is leading the project, targeting completion in Q4. This initiative leverages GRDG Sciences' expertise and addresses the growing market demand for microbial-resistant consumer products. DSS emphasizes the importance of this research in meeting an increasing consumer awareness of health safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.51%
Tags
none
Rhea-AI Summary

Document Security Systems (DSS) announced a three-year contract for approximately $10 million with a leading photography company, enhancing its Premier Packaging subsidiary's portfolio. The contract, valued at around $3.2 million annually, highlights the client's confidence in Premier's capabilities and could lead to further business opportunities. Since management changes in July 2019, Premier has improved operations through investments in manufacturing and processes. As a market leader in secure printing and packaging, Premier services diverse industries, showcasing its adaptable customer service approach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
none
-
Rhea-AI Summary

Document Security Systems (DSS) has announced a special dividend, granting shareholders two shares of Impact BioMedical for each share of DSS held as of September 7, 2020. A second tranche is anticipated but lacks a set record date. The recent acquisition of Impact BioMedical, valued at $382 million, enhances DSS's position in the biomedical field, focusing on R&D for antiviral and medical technologies. This strategic move aims to leverage Impact BioMedical’s assets to improve shareholder value and drive future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.12%
Tags
dividends
-
Rhea-AI Summary

Document Security Systems (DSS) announces an upcoming interview with COO Jason Grady on The RedChip Money Report, airing August 30 at 6 p.m. on Bloomberg International, reaching over 100 million homes in Europe. The interview will delve into DSS's diverse operations, including the recent acquisition of Impact BioMedical and growth strategies aimed at benefiting shareholders. The segment will also be available in the U.S. on multiple channels, showcasing insights into small-cap investment strategies and executive perspectives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.69%
Tags
none
Rhea-AI Summary

DSS has officially closed its acquisition of Impact BioMedical, marking a significant milestone for the company. This acquisition is expected to enhance DSS’s brand protection technology and healthcare sectors. DSS plans to take Impact BioMedical public through an IPO, along with a proposed two-part bonus share dividend for DSS shareholders, offering four Impact shares for each DSS share owned. Impact BioMedical’s technologies have been independently valued between $382 million and $933 million, suggesting potential growth in the healthcare market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.2%
Tags
-
Rhea-AI Summary

Document Security Systems (DSS) reported Q2 2020 financial results, showing a revenue of $3.1 million, down 10% from $3.5 million in Q2 2019 due to COVID-19 impacts. The net loss narrowed to $672,000, or $0.19 per share, compared to a loss of $732,000 in the previous year. DSS strengthened its balance sheet with $16.1 million raised in offerings. A significant contract worth over $24 million was signed by DSS's Premier Packaging subsidiary. DSS also advanced its acquisition of Impact BioMedical, focusing on diversification and shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.45%
Tags
-
Rhea-AI Summary

Document Security Systems (NYSE American: DSS) has successfully completed a public offering of 453,333 shares at $7.50 each, raising gross proceeds of $3.4 million. The funds will support growth in new business lines, acquisition opportunities, and general corporate expenses. Additionally, the underwriter has a 45-day option to purchase 38,533 more shares. This offering was conducted under an effective shelf registration statement with the SEC, aiming to enhance DSS's business operations in brand protection technology and blockchain security.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
Rhea-AI Summary

Document Security Systems (NYSE American: DSS) announced the pricing of a public offering of 453,333 shares at $7.50 per share, aiming for gross proceeds of $3.4 million. The funds will support the growth of new business lines, acquisition opportunities, and general corporate needs. An additional 38,533 shares may be purchased by the underwriter to cover over-allotments. The offering is set to close on July 31, 2020, pending customary conditions. Aegis Capital Corp. is the sole book-running manager for this offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.35%
Tags

FAQ

What is the current stock price of DSS (DSS)?

The current stock price of DSS (DSS) is $0.8701 as of December 23, 2024.

What is the market cap of DSS (DSS)?

The market cap of DSS (DSS) is approximately 6.6M.

What does DSS, Inc. specialize in?

DSS, Inc. specializes in anti-counterfeit, authentication, and diversion protection technologies, offering custom solutions to protect against product diversion, counterfeit, and theft.

What are the key divisions of DSS, Inc.?

DSS, Inc. operates in nine key divisions: Product Packaging, Biotechnology, Consumer Marketing, Commercial Lending, Securities and Investment Management, Alternative Trading, Secure Living, Digital Transformation, and Alternative Energy.

Who are the recent key hires at DSS Wealth Management?

Jim Monaghan has been appointed as Chief Operating Officer and Chief Compliance Officer, and Michael Cheah as Portfolio Manager & Head of Fixed Income at DSS Wealth Management.

What are some recent achievements of DSS, Inc.?

Recent achievements include the successful defense of their ‘040 patent in the Federal Circuit Court and significant revenue growth in their Product Packaging division.

What is the significance of the Impact Biomedical IPO?

The Impact Biomedical IPO is expected to reinforce DSS's growth by allowing shareholders to benefit from the subsidiary's success while maintaining consolidated financials within DSS.

How does DSS, Inc. enhance shareholder value?

DSS enhances shareholder value through strategic acquisitions, periodic IPO spinoffs, and building a diversified portfolio across high-growth sectors.

How can I stay updated on DSS, Inc. news?

You can stay updated by visiting the official website at www.dssworld.com and following their Twitter handles @docsecuritysys and @authentisuite.

What makes DSS, Inc.'s Product Packaging division unique?

Premier Packaging, a subsidiary of DSS, specializes in innovative fiber-based packaging solutions, offering sustainable alternatives to traditional plastic packaging.

Who is the CEO of DSS, Inc.?

Frank Heuszel is the CEO of DSS, Inc.

What recent investment did Chairman Heng Fai Ambrose Chan make in DSS?

Chairman Heng Fai Ambrose Chan recently acquired an additional 672,173 shares of DSS in an open market transaction, signaling strong confidence in the company's strategic direction.

DSS, Inc.

NYSE:DSS

DSS Rankings

DSS Stock Data

6.55M
2.88M
59.28%
2.44%
0.16%
Packaging & Containers
Paperboard Containers & Boxes
Link
United States of America
WEST HENRIETTA